Clinical trials: Male Erectile Dysfunction
Erectile Dysfunction
The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders
Low Intensity Shock Wave Therapy (LI-ESWT) was shown to have a beneficial effect on ED patients responding to PDE5i's. This study aimed to determine the capability of swt to convert PDE5 inhibitor non responders to sexually…
- Trial name
- LI-ESWT (NCT01272297)
- Testing
- LI-ESWT
- Volunteers
- 29 people
- Sponsor
- Rambam Health Care Campus
Erectile Dysfunction, Erectile Dysfunction (ED)
Satisfaction of Patients With Erectile Dysfunction With the Use of Sildenafil Oral Suspension Compared to Orodispersible Tablets
The goal of this observational retrospective study is to to evaluate treatment satisfaction with sildenafil oral suspension in patients with mild-to-moderate ED who were previously taking orodispersible sildenafil.
- Trial name
- SILOROS (NCT07676617)
- Testing
- Sildenafil Oral Suspension Compared to Orodispersible Tablets
- Where
- Italy
- Volunteers
- 55 people
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Prostatic Neoplasms, Erectile Dysfunction Following Radical Prostatectomy
Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy
A study designed to evaluate vascular changes after radical laparoscopic prostatectomy using Doppler ultrasound and the impact of such changes on erectile function and quality of life of patients.
- Trial name
- NCT03241758
- Testing
- Doppler ultrasound
- Volunteers
- 110 people
- Sponsor
- Corporacion Parc Tauli
Prostate Cancer, Erectile Dysfunction
Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction
Erectile dysfunction is a frequent adverse event after radical prostatectomy for prostate cancer. It is the consequence of penile vascular damage, mainly arterial insufficiency and venous leakage associated with fibrosis of the…
- Trial name
- INSTIN (NCT01089387)
- Testing
- injection of bone marrow mononucleated cells
- Where
- France
- Volunteers
- 18 people
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
Erectile Dysfunction
Satisfaction, Confidence and Naturalness in Men With Psychogenic Erectile Dysfunction (ED)
Context and Objectives: Erectile dysfunction severely compromises not only sexual satisfaction, which is well known to be closely linked to overall life satisfaction but is also associated with a lower quality of life, lower…
- Trial name
- NCT01153204
- Testing
- Group Psychotherapy, Group Psychotherapy plus Sildenafil citrate, Sildenafil citrate
- Volunteers
- 30 people
- Sponsor
- Federal University of São Paulo
Erectile Dysfunction, Prostate Cancer
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
The purpose of the study is to compare the safety and effectiveness of Prograf in the prevention of erectile dysfunction in men after a radical prostatectomy.
- Trial name
- NCT00106392
- Testing
- Tacrolimus
- Where
- 6 sites in United States
- Volunteers
- 131 people
- Sponsor
- Astellas Pharma Inc
Impotence
Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
To determine if tadalafil 5 mg daily compared to placebo when given for 12 weeks improves getting and maintaining an erection in men with erectile dysfunction and if there are improvements in the sexual quality of life of the man…
- Trial name
- NCT00422734
- Testing
- tadalafil
- Where
- 19 sites in United States, Austria and 3 more
- Volunteers
- 342 people
- Sponsor
- Eli Lilly and Company
Alcohol, Phosphodiesterase Inhibitor
A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects
The purpose of this study is primarily to evaluate the effects of taking TPN171H tablets with alcohol on blood pressure, pulse,and pharmacokinetic in Chinese healthy male subjects.
- Conditions
- Alcohol, Phosphodiesterase Inhibitor, Erectile Dysfunction
- Trial name
- NCT05316428
- Testing
- TPN171H tablet plus alcohol, alcohol, TPN171H tablet
- Where
- China
- Volunteers
- 19 people, healthy volunteers welcome
- Sponsor
- Vigonvita Life Sciences
Prostatic Hyperplasia, Benign, Erectile Dysfunction
Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
The purpose of this study is to assess the safety and efficacy of the DTT106 in the treatment of erectile dysfunction associated with benign prostatic hyperplasia
- Trial name
- AUSTRÁLIA (NCT06264414)
- Testing
- DTT106, Dutasteride-Tamsulosin
- Where
- Brazil
- Volunteers
- 262 people
- Sponsor
- EMS
Erectile Dysfunction
French Study in Real Life Evaluating Xybilun
Collecting Xybilun (Viagra's generic) efficacity, tolerance, convenience and patients/doctors satisfaction's data at different doses (50-75-100 mg), is the aim of the study.
- Trial name
- XY-FILM (NCT04114240)
- Testing
- Xybilun
- Where
- France
- Volunteers
- 105 people
- Sponsor
- Laboratoires Genévrier
Erectile Dysfunction
Feeling Hot 2: Penile Skin Temperature Measurements of Nocturnal Erections
The Feeling Hot studies focus on the proof-of-principle of using temperature sensing as a tool to detect nocturnal erections. In the Feeling Hot 2 study the penile skin temperature is investigated during nocturnal erections…
- Trial name
- NCT05183620
- Testing
- Feeling Hot sensor system
- Where
- Netherlands
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- St. Antonius Hospital
Type 2 Diabetes, Type 2 Diabetes (T2DM)
PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)
The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.
- Trial name
- NCT07636161
- Testing
- Eroxon®, tadalafil
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- University of Miami
Urologic Diseases, Erectile Dysfunction With Diabetes Mellitus
The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction
Erectile dysfunction (ED) is a complex condition affecting men worldwide. Diabetes mellitus (DM) is one of the most common causes of ED. The prevalence of ED in DM varies around 35-85%.
- Trial name
- NCT04972890
- Testing
- stem cells
- Where
- Indonesia
- Volunteers
- 12 people
- Sponsor
- Universitas Indonesia
Erectile Dysfunction
Evaluation for Restoration of Erectile Dysfunction After Cardioversion Treatment Trial
Erectile and Cognitive function by using the questionnaire and assessment form before sinus conversion
- Trial name
- NCT02742896
- Testing
- Erectile dysfunction
- Where
- South Korea
- Sponsor
- Yong Seog Oh
Erectile Dysfunction
Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction
This study investigates the safety and efficacy of a new dosage form of Vardenafil, an orodispersible tablet (ODT), and compares it to the safety and efficacy of a placebo (inactive) tablet in the treatment of erectile…
- Trial name
- NCT00631969
- Testing
- Vardenafil ODT (STAXYN, BAY38-9456)
- Where
- 47 sites in Belgium, France and 4 more
- Volunteers
- 362 people
- Sponsor
- Bayer
Delayed Graft Function
Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy
Prostate cancer is the most common cancer among Danish men, and the incidence is increasing. Studies have shown a high number needed to treat for each saved prostate cancer related death.
- Trial name
- NCT02240823
- Testing
- adipose derived stem cells
- Where
- Denmark
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Martha Haahr M.D
Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction
Platelet-Rich Plasma for Erectile Dysfunction After Radical Prostatectomy
This study will test whether injections of platelet-rich plasma (PRP) can improve erectile function in men with persistent erectile dysfunction (ED) at least 12 months after nerve-sparing radical prostatectomy for prostate…
- Trial name
- NCT07863388
- Testing
- Autologous Platelet Rich Plasma
- Where
- Denmark
- Volunteers
- 100 people
- Sponsor
- Herlev and Gentofte Hospital
Erectile Dysfunction Due to General Medical Condition, Erectile Dysfunction Following Radical Prostatectomy
Platelet Rich Plasma (PRP) as Terapeutical Option in Erectil Disfunction (DE)
Patients are randomized into 2 groups (A and B), subsequently group A is subjected to a cycle of 6 weekly injections of 3 ml of autologous PRP while group B is subjected to 6 weekly injections of 1 ml of caverject (alprostadil)…
- Conditions
- Erectile Dysfunction Due to General Medical Condition, Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, Erectile Dysfunctions
- Trial name
- NCT06768177
- Testing
- PRP injection, Alprostadil 20 micrograms
- Where
- Italy
- Volunteers
- 60 people
- Sponsor
- Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Prostatic Neoplasms, Urinary Incontinence
Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.
Urinary incontinence and impotence are typical disturbances after radical prostatectomy. Although, several surgical methods are developed to decrease these disturbances, 8% and 50% of the patients suffer from permanent urinary…
- Conditions
- Prostatic Neoplasms, Urinary Incontinence, Erectile Dysfunction
- Trial name
- NCT02526602
- Testing
- Preservation (endopelvic fascia), Opening (endopelvic fascia)
- Where
- Finland
- Volunteers
- 158 people
- Sponsor
- Tampere University Hospital
Erectile Dysfunction
Combined Treatment of Platelet-rich Plasma (PRP) and Low-intensity Extracorporeal Shockwave Therapy (Li-ESWT) on Erectile Dysfunction (ED)
The purpose of this clinical study is mainly to use platelet-rich plasma combined with low-intensity extracorporeal shockwave therapy to treat patients with erectile dysfunction and observe the improvement results.
- Trial name
- NCT04416802
- Testing
- autologous platelet-rich plasma and low-intensity extracorporeal shockwave therapy
- Where
- Taiwan
- Volunteers
- 20 people
- Sponsor
- Taipei Medical University Hospital